Benjamin Toll: Interesting study about nausea prevention with olanzapine

Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared a post on X/Twitter:

“Interesting study in Journal of Clinical Oncology ASCO about nausea prevention with olanzapine
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial | Journal of Clinical Oncology.”

Read further.
Source: Benjamin Toll/X